The full 35k+ dataset is free for everyone. Sign up for favourites, or upgrade to Pro for premium features.

Feature	Free	Sign Up	Pro	Pro+
35,000+ assets	✓	✓	✓	✓
Education library	✗	✓	✓	✓
Filter by Country & Sector	✗	✓	✓	✓
Ad-Free Mobile App Experience	✗	✗	✓	✓
News Article Access	✗	✗	✓	✓
Favourites	3	15	50/mo	Unlimited
Flippener Tool	3	10	30/mo	Unlimited
Comparator Tool	3	5	15/mo	Unlimited
Price	Free	Sign Up	$3.99/mo	$9.99/mo

Create a free account

Already have an account? Log in

Register for your free API key (top 100 assets included). Subscribe for the full 35k+ dataset, fundamentals, and historical data.

Feature	Free	Starter	Growth	Scale
Top 100 assets	✓	✓	✓	✓
Full 35k+ asset list	✗	✓	✓	✓
Fundamentals	✗	✓	✓	✓
Historical data	✗	✓	✓	✓
Calls / month	1,000	10k	100k	1M
Price	Free	$19.99/mo	$49.99/mo	$99.99/mo

View API documentation →

The global leaderboard of wealth: $1.2 Quadrillion of Assets ranked by Market Cap

Companies

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg for BTK-Mediated Diseases - Slideshow

By seekingalpha.com · June 09, 2026 · 1 min read

Read the full article on seekingalpha.com

Comments 0

No comments yet. Be the first to share your thoughts!

← All News articles

—— As Seen On ——

Get the App

Comments 0